C-reactive protein levels in hereditary angioedema

Clinical and Experimental Immunology

Volumn 177, Issue 1, 2014, Pages 280-286

  Hofman, Z L M ^a   Relan, A ^b   Hack, C E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Pharming Group NV   (Netherlands)

Author keywords

Bradykinin receptor; C reactive protein; Hereditary angioedema

Indexed keywords

ANDROGEN; BRADYKININ B2 RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1S INHIBITOR; FRESH FROZEN PLASMA;

ABDOMINAL DISEASE; ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BODY MASS; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; VISUAL ANALOG SCALE;

BRADYKININ RECEPTOR; C-REACTIVE PROTEIN; HEREDITARY ANGIOEDEMA;

ABDOMEN; ACUTE DISEASE; ADOLESCENT; AGED; ANGIOEDEMAS, HEREDITARY; ASYMPTOMATIC DISEASES; BRADYKININ; C-REACTIVE PROTEIN; COMPLEMENT C1 INACTIVATOR PROTEINS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 84904243938     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12314     Document Type: Article

References (41)

1. Zuraw BJ. Hereditary angioedema. N Engl J Med 2008; 359:1027-1036.
2. Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale LC, Cicardi M. Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. Mol Immunol 2008; 45:3536-3544.
3. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001; 161:2417-2429.
4. Kusuma A, Relan A, Knulst AC etal. Clinical impact of peripheral attacks in hereditary angioedema patients. Am J Med 2012; 125:17-24.
5. Davis AE III. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am 2006; 26:633-651.
6. Kaplan AP. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol 2010; 126:918-925.
7. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005; 57:27-77.
8. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 2005; 99:6-38.
9. Maurer M, Bader M, Bas M etal. New topics in bradykinin research. Allergy 2011; 66:397-1406.
10. Phagoo SB, Yaqoob M, McIntyre P, Jones C, Burgess GM. Cytokines increase B1 bradykinin receptor mRNA and protein levels in human lung fibroblasts. Biochem Soc Trans 1997; 25:43S.
11. Zhou X, Polgar P, Taylor L. Roles for interleukin-1beta, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression. Biochem J 1998; 330:361-366.
12. Phagoo SB, Yaqoob M, Herrera-Martinez E, McIntyre P, Jones C, Burgess GM. Regulation of bradykinin receptor gene expression in human lung fibroblasts. Eur J Pharmacol 2000; 397:237-246.
13. Decarie A, Adam A, Couture R. Effects of captopril and Icatibant on bradykinin (BK) and des [Arg9] BK in carrageenan induced edema. Peptides 1996; 17:1009-1015.
14. Cruwys SC, Garrett NE, Perkins MN, Blake DR, Kidd BL. The role of bradykinin B1 receptors in the maintenance of intraarticular plasma extravasation in chronic antigen-induced arthritis. Br J Pharmacol 1994; 113:940-944.
15. Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE III. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 2002; 109:1057-1063.
16. Bossi F, Fischetti F, Regoli D etal. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol 2009; 124:1303-1310.
17. Toniatti C, Demartis A, Monaci P, Nicosia A, Ciliberto G. Synergistic transactivation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites. EMBO J 1990; 9:4467-4475.
18. Majello B, Arcone R, Toniatti C, Ciliberto G. Constitutive and IL-6 induced nuclear factors that interact with the human C-reactive protein promoter. EMBO J 1990; 9:457-465.
19. Taylor AW, Ku NO, Mortensen RF. Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-beta. J Immunol 1990; 145:2507-2513.
20. Li SP, Goldmann ND. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements. Biochemistry 1996; 35:9060-9068.
21. Zhang D, Sun M, Samols D, Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem 1996; 271:9503-9509.
22. Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T. Fibrates downregulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation. Blood 2003; 101:545-551.
23. van Doorn MB, Burggraaf J, van Dam T etal. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol 2005; 116:876-883.
24. Choi G, Soeters MR, Farkas H etal. Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion 2007; 47:1028-1032.
25. Zuraw B, Cicardi M, Levy RJ etal. Recombinant human C1-inhibitorfor the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol 2010; 126:821-827.
26. Pharming Technologies BV. Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks. In: ClinicalTrials.gov [internet]. Bethesda (MD): National Library of Medicine (US), 2000. Available at: http://clinicaltrials.gov/show/NCT01188564 (accessed 14 January 2014). NLM Identifier: NCT01188564.
27. Hussain TM, Kim DH. C-Reactive protein and erythrocyte sedimentation rate in orthopaedics. Univ Pa Orthop J 2002; 15:13-16.
28. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 11:1805-1812.
29. Ohsawa I, Nagamachi S, Suzuki H etal. Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema. BMC Gastroenterol 2013; 13:123-128.
30. Arcoleo F, Salemi M, La Porta A etal. Upregulation of cytokines and IL-17 in patients with hereditary angioedema. Clin Chem Lab Med 2014; 52:91-93.
31. Patel DN, King CA, Bailey SR etal. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBPβ activation. J Biol Chem 2007; 282:27229-27238.
32. Coelho dos Santos JS, Menezes CA, Villani FN etal. Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces humanT helper type 17 cells. Clin Exp Immunol 2010; 162:528-536.
33. Monteiro AC, Scovino A, Raposo S etal. Kinin danger signals proteolytically released by gingipain induce fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. J Immunol 2009; 15:3700-3711.
34. Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012; 30:149-173.
35. Balzan S, del Almeida Quadros C, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 2007; 22:464-471.
36. Wang DZ, Chao L, Chao J. Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension 1997; 29:488-493.
37. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002; 347:621-622.
38. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351:1693-1697.
39. Blaukat A, Micke P, Kalatskaya I, Faussner A, Müller-Esterl W. Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure. Am J Physiol Heart Circ Physiol 2003; 284:1909-1916.
40. Hecquet C, Becker RP, Tan F, Erdös EG. Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane. Int Immunopharmacol 2002; 2:1795-1806.
41. Bas M, Hoffmann TK, Bier H, Kojda G. Increased C-reactive protein in ACE-inhibitor-induced angioedema. Br J Clin Pharmacol 2005; 59:233-238.